MMDJX Performance — MassMutual Select T. Rowe Price Retirement 2055 Fund, Class I
Data updated: 2025-08-25
MMDJX returned +12.46% over one year to Jun 2025. Annualised returns are +15.13% over 3 years and +11.96% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $153, against $141 for the category, and to $112 over one year, against $112. Volatility over the past three years was 14.31% a year. In the 12 months to Jun 2025 the fund lost a net $239.4M, and assets reached $104.92M.
MMDJX Growth of $100
What $100 invested in MassMutual Select T. Rowe Price Retirement 2055 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | MMDJX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $112 | $112 |
| 3 years (Jul 2022 – Jun 2025) | $153 | $141 |
| 5 years (Jul 2020 – Jun 2025) | $176 | $154 |
| Since data start (Jul 2019 – Jun 2025) | $182 | $159 |
MMDJX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +12.46% |
| 3 years (annualised) | +15.13% |
| 5 years (annualised) | +11.96% |
MMDJX Annual Returns
Calendar-year total returns of MassMutual Select T. Rowe Price Retirement 2055 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +8.14% |
| 2024 | +14.38% |
| 2023 | +21.06% |
| 2022 | −19.13% |
| 2021 | +17.39% |
| 2020 | +18.43% |
| 2019 (Jul–Dec) | +7.86% |
MMDJX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −3.0% | −0.3% | +3.2% | −0.2% | +4.7% | +3.7% | — | — | — | — | — | — |
| 2024 | +3.7% | +4.6% | +0.1% | +1.0% | +4.0% | −3.5% | +1.5% | +2.4% | +2.1% | −3.9% | +4.2% | −2.2% |
| 2023 | +2.2% | −2.7% | +7.1% | +5.8% | −1.0% | +1.3% | −4.1% | −2.6% | +3.7% | +5.2% | +8.3% | −2.8% |
| 2022 | +1.2% | −2.4% | −5.5% | −7.6% | +0.3% | −8.2% | −8.8% | −3.9% | +6.6% | −4.4% | +7.3% | +6.2% |
| 2021 | +2.3% | +3.6% | −0.2% | +1.1% | +1.2% | +4.3% | −3.8% | +2.6% | +0.6% | +3.1% | −3.0% | +4.8% |
| 2020 | −14.1% | −6.6% | −0.7% | +3.0% | +5.2% | +10.8% | −2.9% | +5.2% | +5.1% | +4.4% | +11.5% | −1.0% |
| 2019 | — | — | — | — | — | — | +1.2% | −1.4% | +0.4% | +3.1% | +2.7% | +1.6% |
MMDJX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 14.31%
- 3-year Sharpe ratio: 0.74 (vs 4.5% risk-free rate)
- Best month: +8.29% (Nov 2023)
- Worst month: −8.75% (Jul 2022)
MMDJX Fund Flows
Monthly money in and out of MassMutual Select T. Rowe Price Retirement 2055 Fund, from SEC Form N-PORT.
- 12-month net flow: −$239.4M
- 12-month gross sales (incl. reinvestments): $92.9M
- Sales ÷ redemptions: 0.28×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $1.7M | $1.8M | −$9K |
| May 2025 | $2.3M | $1.5M | $879K |
| Apr 2025 | $2.3M | $10.4M | −$8.1M |
| Mar 2025 | $3.7M | $240.8M | −$237.1M |
| Feb 2025 | $2.3M | $5.4M | −$3.1M |
| Jan 2025 | $2.0M | $4.7M | −$2.7M |
| Dec 2024 | $8.5M | $5.7M | $2.8M |
| Nov 2024 | $6.7M | $14.1M | −$7.4M |
| Oct 2024 | $39.2M | $10.3M | $29.0M |
| Sep 2024 | $7.6M | $9.1M | −$1.5M |
| Aug 2024 | $9.4M | $15.8M | −$6.4M |
| Jul 2024 | $7.1M | $12.8M | −$5.7M |
MMDJX Assets Under Management
Net assets of MassMutual Select T. Rowe Price Retirement 2055 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $104.92M |
| 2025-03-31 | $103.72M |
| 2024-12-31 | $345.58M |
| 2024-09-30 | $359.93M |
| 2024-06-30 | $352.38M |
| 2024-03-31 | $495.03M |
| 2023-12-31 | $431.97M |
| 2023-09-30 | $388.47M |
| 2023-06-30 | $390.43M |
| 2023-03-31 | $357.24M |
| 2022-12-31 | $328.36M |
| 2022-09-30 | $294.80M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.